Tech Company Financing Transactions

Achaogen Funding Round

Achaogen closed a $56 million Series C financing round on 4/7/2010. Backers included Frazier Healthcare Partners, 5AM Ventures and Alta Partners.

Transaction Overview

Company Name
Achaogen
Announced On
4/7/2010
Transaction Type
Venture Equity
Amount
$56,000,000
Round
Series C
Investors

Frazier Healthcare Partners (Lead Investor) (Robert More)

5AM Ventures (Scott Rocklage)

Alta Partners

Arch Venture Partners

Domain Associates

Venrock (Bryan Roberts)

Versant Ventures (Camille Samuels)

Proceeds Purpose
Our mission is to discover and develop life-saving antibiotics. This financing together with non-dilutive capital that we have secured through partnerships with various government agencies will enable us to advance multiple clinical programs, including conducting a Phase 2 study in complicated urinary tract infections of ACHN-490, our lead candidate for multi-drug resistant bacterial infections.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Tower Pl. 400
San Francisco, CA 94080
USA
Phone
(833) 252-6400
Website
www.achaogen.com
Email Address
[email protected]
Overview
Achaogen is dedicated to addressing serious medical needs caused by the development of bacterial resistance to antibiotics.
Profile
Achaogen LinkedIn Company Profile
Social Media
Achaogen Company Twitter Account
Company News
Achaogen News
Facebook
Achaogen on Facebook
YouTube
Achaogen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Blake Wise
  Blake Wise LinkedIn Profile  Blake Wise Twitter Account  Blake Wise News  Blake Wise on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/7/2010: Quirky venture capital transaction
Next: 4/7/2010: Cogenra Solar venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.